DNA DISCOVERY


The sequencing and annotation of the human genomics is in its first phase. This mammoth effort, however, will merely provide a baseline for the thousands of minor variations in DNA composition (polymorphisms) that confer major individual differences in a person’s susceptibility to disease. Examples of common polymorphisms associated with an increased risk of disease include the ApoE4 allele and Alzheimer disease and the APC I1307K allele and colon cancer. DNA sequence analysis is one means to get at these differences, but a far more efficient and powerful approach is the use of identified single nucleotide polymorphisms (SNPs).These SNPs, which occur at an estimated rate of 1 in every 1,000 base pairs of DNA, are becoming an important tool for scanning the genome in pedigree-based linkage analysis, for mapping the genetics of disease in individuals in the population using association methods, and for directly identifying polymorphisms that contribute to a particular phenotype/disease. Thus, SNPs will be particularly important for mapping and discovering the genes associated with common diseases. 

The CGB will recruit at least 2 molecular geneticists and/or genetic epidemiologists to establish a core facility to support sequence- and SNP-based analysis of the genome to enable researchers in the basic and clinical sciences to determine the role of genetic alterations in health and disease. 


Hardware

 


Recent Pubs

PubMed search for Dr. Weikuan Gu
PubMed search for Dr. Robyn Wallace
PubMed search for Dr. Ronald M. Adkins


Update

 


Return to Cores Main.